{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:16:31Z","timestamp":1779923791023,"version":"3.53.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.psychres.2024.115967","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T15:23:01Z","timestamp":1715700181000},"page":"115967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Alterations in plasma endocannabinoid concentrations among individuals with major depression treated with electroconvulsive therapy"],"prefix":"10.1016","volume":"337","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8581-784X","authenticated-orcid":false,"given":"Esther","family":"Bloemhof-Bris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Meiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liron","family":"Sulimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon Nir","family":"Genesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gay","family":"Wexler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzhak","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioulia","family":"Burshtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shmuel","family":"Hirschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kfir","family":"Feffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Stryjer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9712-1217","authenticated-orcid":false,"given":"Assaf","family":"Shelef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2024.115967_bib0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2013.10.006","article-title":"Depressive behavior in the forced swim test can be induced by TRPV1 receptor activity and is dependent on NMDA receptors","volume":"79","author":"Abdelhamid","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.psychres.2024.115967_bib0009","unstructured":"Administration, F.A.D., 2018. Bioanalytical Method Validation Guidance for Industry. https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf."},{"issue":"1","key":"10.1016\/j.psychres.2024.115967_bib0002","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drudis.2016.08.005","article-title":"Targeting the endocannabinoid system: future therapeutic strategies","volume":"22","author":"Aizpurua-Olaizola","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.psychres.2024.115967_bib0003","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.3390\/ijms21103421","article-title":"TRPV1: structure, endogenous agonists, and mechanisms","volume":"21","author":"Ben\u00edtez-Angeles","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psychres.2024.115967_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121336","article-title":"Cannabinoidomics - An analytical approach to understand the effect of medical Cannabis treatment on the endocannabinoid metabolome","volume":"219","author":"Berman","year":"2020","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/j.psychres.2024.115967_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"9","key":"10.1016\/j.psychres.2024.115967_bib0006","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd.2018.115","article-title":"New approaches and challenges to targeting the endocannabinoid system","volume":"17","author":"Di Marzo","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.psychres.2024.115967_bib0007","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/npp.2012.100","article-title":"Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans","volume":"37","author":"Dlugos","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2024.115967_bib0008","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s11064-018-2591-y","article-title":"Effects of rTMS on hippocampal endocannabinoids and depressive-like behaviors in adolescent rats","volume":"43","author":"Fang","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.psychres.2024.115967_bib0010","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/ijo.2009.132","article-title":"Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions","volume":"33","author":"Fong","year":"2009","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.psychres.2024.115967_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110096","article-title":"Endocannabinoid system in psychotic and mood disorders, a review of human studies","volume":"106","author":"Garani","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115967_bib0012","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tips.2013.08.008","article-title":"Amygdala FAAH and anandamide: mediating protection and recovery from stress","volume":"34","author":"Gunduz-Cinar","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.psychres.2024.115967_bib0013","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.psychres.2024.115967_bib0014","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115967_bib0015","doi-asserted-by":"crossref","first-page":"e62741","DOI":"10.1371\/journal.pone.0062741","article-title":"Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder","volume":"8","author":"Hauer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.psychres.2024.115967_bib0016","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.euroneuro.2020.09.005","article-title":"Serum endocannabinoid levels in suicide attempters: a pilot study","volume":"40","author":"Herranz-Herrer","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2024.115967_bib0017","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1471-4159.2007.04688.x","article-title":"Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity","volume":"103","author":"Hill","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psychres.2024.115967_bib0018","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1471-4159.2008.05567.x","article-title":"Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment","volume":"106","author":"Hill","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psychres.2024.115967_bib0019","series-title":"Endocannabinoidome","author":"Iannotti","year":"2018"},{"key":"10.1016\/j.psychres.2024.115967_bib0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pbb.2015.04.001","article-title":"Antidepressant-like effects of oleoylethanolamide in a mouse model of chronic unpredictable mild stress","volume":"133","author":"Jin","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psychres.2024.115967_bib0021","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00406-017-0789-7","article-title":"Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study","volume":"267","author":"Kranaster","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2024.115967_bib0022","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fpsyg.2020.00080","article-title":"Effects of electroconvulsive therapy on depression and its potential mechanism","volume":"11","author":"Li","year":"2020","journal-title":"Front. Psychol."},{"issue":"4","key":"10.1016\/j.psychres.2024.115967_bib0023","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/ALN.0b013e318167aef7","article-title":"Additive interaction of the cannabinoid receptor I agonist arachidonyl-2-chloroethylamide with etomidate in a sedation model in mice","volume":"108","author":"Meybohm","year":"2008","journal-title":"Anesthesiology"},{"issue":"9600","key":"10.1016\/j.psychres.2024.115967_bib0024","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(07)61705-X","article-title":"Depression and anxiety with rimonabant","volume":"370","author":"Mitchell","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.psychres.2024.115967_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1176\/foc.6.1.foc155","article-title":"Efficacy of ECT in depression: a meta-analytic review","volume":"6","author":"Pagnin","year":"2008","journal-title":"Focus"},{"key":"10.1016\/j.psychres.2024.115967_bib0026","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/er.2005-0009","article-title":"The emerging role of the endocannabinoid system in endocrine regulation and energy balance","volume":"27","author":"Pagotto","year":"2006","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.psychres.2024.115967_bib0027","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.expneurol.2010.03.018","article-title":"The endocannabinoid system and psychiatric disorders","volume":"224","author":"Parolaro","year":"2010","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.psychres.2024.115967_bib0028","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjp.0705334","article-title":"The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase","volume":"139","author":"Patel","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115967_bib0029","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1210\/en.2004-0638","article-title":"Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"145","author":"Patel","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.psychres.2024.115967_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104905","article-title":"Blood endocannabinoid levels in patients with panic disorder","volume":"122","author":"Petrowski","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2024.115967_bib0031","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.biopsych.2004.11.017","article-title":"Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression","volume":"57","author":"Pfennig","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115967_bib0032","volume":"10","author":"Posner","year":"2008"},{"key":"10.1016\/j.psychres.2024.115967_bib0033","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuropharm.2019.02.026","article-title":"Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants","volume":"149","author":"Romero-Sanchiz","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psychres.2024.115967_bib0034","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12640-014-9465-0","article-title":"Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures","volume":"26","author":"Smaga","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.psychres.2024.115967_bib0035","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3892\/etm.2021.10716","article-title":"Efficacy of electroconvulsive therapy as a potential first-choice treatment in treatment-resistant depression (Review)","volume":"22","author":"Trifu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.psychres.2024.115967_bib0036","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.biopsych.2004.11.033","article-title":"Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims","volume":"57","author":"Vinod","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115967_bib0037","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuint.2006.05.002","article-title":"Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system","volume":"49","author":"Vinod","year":"2006","journal-title":"Neurochem. Int."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517812400252X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517812400252X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T22:56:30Z","timestamp":1736204190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517812400252X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":37,"alternative-id":["S016517812400252X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2024.115967","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in plasma endocannabinoid concentrations among individuals with major depression treated with electroconvulsive therapy","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2024.115967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115967"}}